A new approach for the treatment of chronic venous disease: the impact of extracorporeal shockwave therapy - a case report
DOI:
https://doi.org/10.11606/issn.2317-0190.v32i1a232768Keywords:
Limb Salvage, Venous Insufficiency, Extracorporeal Shockwave Therapy, Perfusion, AmputeesAbstract
Chronic venous disease (CVD) is a prevalent condition that can lead to venous ulcers, which in severe cases are associated with an increased risk of amputation. Conventional treatments have shown limited efficacy, necessitating innovative approaches. Focal extracorporeal shockwaves (f-ESW) have been proven beneficial in musculoskeletal and cardiovascular conditions and have recently been investigated for potential use in CVD and peripheral arterial disease (PAD). We report the effect of f-ESW in treating vascular insufficiency in an 80-year-old woman who underwent left transfemoral amputation due to osteomyelitis following a venous ulcer in 2022. Upon initial evaluation, the patient exhibited signs of reduced peripheral perfusion and significant edema in the contralateral limb, with signs indicating an increased risk of amputation. After three sessions of f-ESW, we observed reduced erythema and edema, improved perfusion, and increased local temperature. Thus, f-ESW may represent a promising therapeutic option for patients with severe CVD, offering significant benefits in amputation prevention and management of severe CVD.
Downloads
References
Vincent JR, Jones GT, Hill GB, van Rij AM. Failure of microvenous valves in small superficial veins is a key to the skin changes of venous insufficiency. J Vasc Surg. 2011;54(6 Suppl):62S-9S.e1-3. Doi: https://doi.org/10.1016/j.jvs.2011.06.085
Kikuchi R, Nhuch C, Drummond DAB, Santiago FR, Coelho F, Mauro FO, et al. Brazilian guidelines on chronic venous disease of the Brazilian Society of Angiology and Vascular Surgery. J Vasc Bras. 2023;22:e20230064. Doi: https://doi.org/10.1590/1677-5449.202300642
McLafferty RB, Passman MA, Caprini JA, Rooke TW, Markwell SA, Lohr JM, et al. Increasing awareness about venous disease: The American Venous Forum expands the National Venous Screening Program. J Vasc Surg. 2008;48(2):394-9. Doi: https://doi.org/10.1016/j.jvs.2008.03.041
Prochaska JH, Arnold N, Falcke A, Kopp S, Schulz A, Buch G, et al. Chronic venous insufficiency, cardiovascular disease, and mortality: a population study. Eur Heart J. 2021;42(40):4157-4165. Doi: https://doi.org/10.1093/eurheartj/ehab495
Gohel MS, Taylor M, Earnshaw JJ, Heather BP, Poskitt KR, Whyman MR. Risk factors for delayed healing and recurrence of chronic venous leg ulcers--an analysis of 1324 legs. Eur J Vasc Endovasc Surg. 2005;29(1):74-7. Doi: https://doi.org/10.1016/j.ejvs.2004.10.002
Nelson EA, Harper DR, Prescott RJ, Gibson B, Brown D, Ruckley CV. Prevention of recurrence of venous ulceration: randomized controlled trial of class 2 and class 3 elastic compression. J Vasc Surg. 2006;44(4):803-8. Doi: https://doi.org/10.1016/j.jvs.2006.05.051
Finlayson K, Edwards H, Courtney M. Factors associated with recurrence of venous leg ulcers: a survey and retrospective chart review. Int J Nurs Stud. 2009;46(8):1071-8. Doi: https://doi.org/10.1016/j.ijnurstu.2008.12.012
Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons N. Burden of venous leg ulcers in the United States. J Med Econ. 2014;17(5):347-56. Doi: https://doi.org/10.3111/13696998.2014.903258
Auersperg V, Trieb K. Extracorporeal shock wave therapy: an update. EFORT Open Rev. 2020;5(10):584-592. Doi: https://doi.org/10.1302/2058-5241.5.190067
Kaller M, Faber L, Bogunovic N, Horstkotte D, Burchert W, Lindner O. Cardiac shock wave therapy and myocardial perfusion in severe coronary artery disease. Clin Res Cardiol. 2015;104(10):843-9. Doi: https://doi.org/10.1007/s00392-015-0853-0
Wu X, Gu M, Ma Y, Song P, Fang C. Observation of the effectiveness of clinical indicators of cardiac shock wave therapy in patients with ischemic heart disease: A systematic review and meta-analysis. Front Cardiovasc Med. 2023;10:1088811. Doi: https://doi.org/10.3389/fcvm.2023.1088811
Raza A, Harwood A, Totty J, Smith G, Chetter I. Extracorporeal Shockwave Therapy for Peripheral Arterial Disease: A Review of the Potential Mechanisms of Action. Ann Vasc Surg. 2017;45:294-298. Doi: https://doi.org/10.1016/j.avsg.2017.06.133
Saito S, Ishii T, Kamogawa Y, Watanabe R, Shirai T, Fujita Y, et al. Extracorporeal Shock Wave Therapy for Digital Ulcers of Systemic Sclerosis: A Phase 2 Pilot Study. Tohoku J Exp Med. 2016;238(1):39-47. Doi: https://doi.org/10.1620/tjem.238.39
Bagatini OA, Bertin C, Guarita MLC, Hong F, Shinzato GT, Imamura M, et al. Uso da terapia por ondas de choque para o tratamento do linfedema associado ao câncer de mama: uma revisão sistemática. Acta Fisiatr. 2018;25(4):205-210. Doi: https://doi.org/10.11606/issn.2317-0190.v25i4a163839
Kubo M, Li TS, Kamota T, Ohshima M, Shirasawa B, Hamano K. Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis. J Vasc Surg. 2010;52(2):429-34. Doi: https://doi.org/10.1016/j.jvs.2010.03.017
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Acta Fisiátrica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
O conteúdo do periódico está licenciado sob uma Licença Creative Commons BY-NC-SA. Esta licença permite que outros remixem, adaptem e criem a partir do seu trabalho para fins não comerciais, desde que atribuam ao autor o devido crédito e que licenciem as novas criações sob termos idênticos.
